MESO
Mesoblast limited.

5,263
Mkt Cap
$1.85B
Volume
236,373.00
52W High
$21.50
52W Low
$9.61
PE Ratio
-19.41
MESO Fundamentals
Price
$15.56
Prev Close
$14.32
Open
$15.18
50D MA
$16.52
Beta
1.44
Avg. Volume
202,554.62
EPS (Annual)
-$0.8443
P/B
3.21
Rev/Employee
$211,960.04
$1,281.89
Loading...
Loading...
News
all
press releases
Mesoblast (NASDAQ:MESO) Trading Up 9.3% - What's Next?
Mesoblast (NASDAQ:MESO) Shares Up 9.3% - Still a Buy...
MarketBeat·43m ago
News Placeholder
More News
News Placeholder
A Key "Master" Protein That Declines by Half After Age 40. One Company Found a Way to Restore It.
A Key 'Master' Protein That Declines by Half After Age 40. One Company Found a Way to Restore It. A Key 'Master' Protein That Declines by Half After Age 40. One Company Found a Way to Restore It. PR...
PR Newswire·7d ago
News Placeholder
Mesoblast (NASDAQ:MESO) Shares Cross Below 50-Day Moving Average - Time to Sell?
Mesoblast (NASDAQ:MESO) Stock Price Crosses Below Fifty Day Moving Average - Should You Sell...
MarketBeat·12d ago
News Placeholder
Mesoblast (NASDAQ:MESO) Shares Gap Up - Here's Why
Mesoblast (NASDAQ:MESO) Shares Gap Up - Here's Why...
MarketBeat·20d ago
News Placeholder
Mesoblast (NASDAQ:MESO) Stock Price Down 8.5% - Here's What Happened
Mesoblast (NASDAQ:MESO) Shares Down 8.5% - Here's What Happened...
MarketBeat·23d ago
News Placeholder
Mesoblast (NASDAQ:MESO) Shares Gap Down - Here's What Happened
Mesoblast (NASDAQ:MESO) Shares Gap Down - Here's What Happened...
MarketBeat·26d ago
News Placeholder
Mesoblast H1 Earnings Call Highlights
Mesoblast (NASDAQ:MESO) executives highlighted strong early commercial momentum for its cell therapy Ryoncil and outlined multiple regulatory and clinical milestones ahead during the company's...
MarketBeat·27d ago
News Placeholder
What's Next: Mesoblast's Earnings Preview
read more...
Benzinga·28d ago
News Placeholder
Mesoblast (MESO) Projected to Post Quarterly Earnings on Thursday
Mesoblast (NASDAQ:MESO) will be releasing earnings before the market opens on Thursday, February 26. (View Earnings Report at...
MarketBeat·1mo ago
News Placeholder
Mesoblast (NASDAQ:MESO) Stock Price Passes Below 50-Day Moving Average - Time to Sell?
Mesoblast (NASDAQ:MESO) Stock Crosses Below 50-Day Moving Average - Should You Sell...
MarketBeat·1mo ago
<
1
2
...
>

Latest MESO News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.